About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
MGI:97384
141 phenotypes from 20 alleles in 27 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Ntrk2tm1.1Lfr/Ntrk2+
involves: 129X1/SvJ
abnormal peripheral nervous system regeneration J:116954
Ntrk2tm1.1Tes/Ntrk2+
B6.129S1-Ntrk2tm1.1Tes
increased thigmotaxis J:144845
Ntrk2tm1.1Tes/Ntrk2tm1.1Tes
B6.129S1-Ntrk2tm1.1Tes
abnormal amygdala morphology J:144845
abnormal dendrite morphology J:144845
increased thigmotaxis J:144845
Ntrk2tm1.1Tes/Ntrk2tm1.1Tes
involves: 129S1/Sv
abnormal sensory neuron innervation pattern J:192549
Ntrk2tm1b(EUCOMM)Wtsi/Ntrk2+
C57BL/6N-Ntrk2tm1b(EUCOMM)Wtsi/H
abnormal rib morphology J:211773
decreased prepulse inhibition J:211773
increased circulating HDL cholesterol level J:211773
increased lean body mass J:211773
Ntrk2tm1b(EUCOMM)Wtsi/Ntrk2tm1b(EUCOMM)Wtsi
C57BL/6N-Ntrk2tm1b(EUCOMM)Wtsi/H
preweaning lethality, incomplete penetrance J:211773
Ntrk2tm1Bbd/Ntrk2tm1Bbd
involves: 129S2/SvPas
abnormal barrel cortex morphology J:103935
abnormal cerebellum development J:49472
abnormal Purkinje cell dendrite morphology J:49472
abnormal sensory neuron innervation pattern J:103935, J:104489
abnormal somatic nervous system morphology J:104489
postnatal lethality, complete penetrance J:104489
small cochlear ganglion J:104489
small geniculate ganglion J:104489
small L4 dorsal root ganglion J:104489
small nodose ganglion J:49472, J:104489
small petrosal ganglion J:104489
small trigeminal ganglion J:104489
small vestibular ganglion J:49472, J:104489
Ntrk2tm1Bbd/Ntrk2tm1Bbd
involves: 129S2/SvPas * C57BL/6
abnormal cochlear ganglion morphology J:29245
abnormal cochlear OHC afferent innervation pattern J:29245
abnormal crista ampullaris neuroepithelium morphology J:29245
abnormal sensory neuron innervation pattern J:29245
abnormal utricular macula morphology J:29245
abnormal vestibular ganglion morphology J:29245
abnormal vibrissae reflex J:56847
absent suckling reflex J:56847
decreased motor neuron number J:56847
neonatal lethality, incomplete penetrance J:56847
no swallowing reflex J:56847
small cochlear ganglion J:29245
small dorsal root ganglion J:56847
small facial motor nucleus J:56847
small trigeminal ganglion J:56847
small vestibular ganglion J:29245
Ntrk2tm1Bbd/Ntrk2tm1Kln
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
abnormal cochlear OHC afferent innervation pattern J:84871
abnormal cochlear sensory epithelium morphology J:84871
abnormal inner ear vestibule morphology J:84871
abnormal sensory neuron innervation pattern J:84871
abnormal type I vestibular cell J:84871
increased or absent distortion product otoacoustic emission threshold J:84871
normal mortality/aging J:84871
Ntrk2tm1Bbd/Ntrk2tm2Kln
Tg(Camk2a-cre)159Kln/0
involves: 129S2/SvPas * CBA/J
abnormal avoidance learning behavior J:58229
abnormal contextual conditioning behavior J:58229
abnormal learning/memory/conditioning J:58229
abnormal myelination J:58229
abnormal spatial learning J:58229
increased thigmotaxis J:58229
reduced long-term potentiation J:58229
Ntrk2tm1Bxu/Ntrk2tm1Bxu
involves: 129 * C57BL/6
abnormal dopaminergic neuron morphology J:170724
abnormal innervation J:170724
decreased dopaminergic neuron number J:170724
gliosis J:170724
increased susceptibility to dopaminergic neuron neurotoxicity J:170724
normal mortality/aging J:170724
neurodegeneration J:170724
Ntrk2tm1Ddg/Ntrk2tm1Ddg
involves: 129P2/OlaHsd * C57BL/6
no abnormal phenotype detected J:99603
Ntrk2tm1Ddg/Ntrk2tm1Ddg
involves: 129S6/SvEvTac
abnormal sensory neuron innervation pattern J:192549
Ntrk2tm1Jom/Ntrk2+
Tg(Syn1-cre)671Jxm/0
involves: 129/Sv * C57BL/6 * ICR
decreased kindling response J:91467
Ntrk2tm1Jom/Ntrk2tm1Jom
Tg(GFAP-cre)25Mes/0
involves: FVB/N
normal nervous system phenotype J:103935
Ntrk2tm1Jom/Ntrk2tm1Jom
Tg(Syn1-cre)671Jxm/0
involves: 129/Sv * C57BL/6 * ICR
decreased kindling response J:91467
Ntrk2tm1Kln/Ntrk2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
normal endocrine/exocrine gland phenotype J:210229
normal growth/size/body region phenotype J:210229
Ntrk2tm1Kln/Ntrk2tm1Kln
involves: 129S1/Sv * 129X1/SvJ
abnormal inner ear vestibule morphology J:84871
abnormal sensory neuron innervation pattern J:75365, J:84871
abnormal somatic sensory system morphology J:49472, J:75365
abnormal synapse morphology J:75365
abnormal vestibular nerve morphology J:75365
abnormal vestibulocochlear nerve morphology J:75365
absent hair-down neurons J:49472
decreased sensory neuron number J:75365
hyperactivity J:49472
small nodose ganglion J:49472
small vestibular ganglion J:49472
Ntrk2tm1Lfp/Ntrk2tm1Lfp
involves: 129
abnormal barrel cortex morphology J:103935
abnormal sensory neuron innervation pattern J:103935
Ntrk2tm1Lfp/Ntrk2tm1Lfp
involves: 129 * C57
abnormal sensory neuron innervation pattern J:104489
abnormal somatic nervous system morphology J:104489
postnatal lethality, complete penetrance J:104489
small cochlear ganglion J:104489
small geniculate ganglion J:104489
small nodose ganglion J:104489
small petrosal ganglion J:104489
small trigeminal ganglion J:104489
small vestibular ganglion J:104489
Ntrk2tm1Lfr/Ntrk2+
involves: 129X1/SvJ
abnormal retina ganglion cell morphology J:122929
Ntrk2tm1Lfr/Ntrk2tm1Lfr
involves: 129X1/SvJ
abnormal retina ganglion cell morphology J:119332, J:122929
decreased retina ganglion cell number J:119332
Ntrk2tm1Lfr/Ntrk2tm1Lfr
Tg(Camk2a-cre)1Lfr/0
involves: 129X1/SvJ * C57BL/6 * DBA
abnormal dendrite morphology J:77452
abnormal neuron morphology J:77452
abnormal somatosensory cortex morphology J:77452
abnormal visual cortex morphology J:77452
decreased neuron number J:77452
Ntrk2tm1Mini/Ntrk2+
involves: 129P2/OlaHsd * C57BL/6
abnormal liver morphology J:210229
adrenal cortical hyperplasia J:210229
normal behavior/neurological phenotype J:210229
increased abdominal fat pad weight J:210229
increased adrenal gland zona fasciculata size J:210229
increased circulating adrenocorticotropin level J:210229
increased circulating insulin level J:210229
increased circulating leptin level J:210229
increased susceptibility to age related obesity J:210229
Ntrk2tm1Mini/Ntrk2tm1Mini
involves: 129P2/OlaHsd
abnormal excitatory postsynaptic potential J:130626
abnormal long-term potentiation J:130626
impaired synaptic plasticity J:130626
Ntrk2tm1Rohr/Ntrk2+
Not Specified
abnormal circulating corticosterone level J:179918
decreased circulating adrenocorticotropin level J:179918
decreased circulating corticosterone level J:179918
decreased circulating follicle stimulating hormone level J:88782
Ntrk2tm1Rohr/Ntrk2tm1Rohr
involves: ICR
abnormal breathing pattern J:89227
abnormal eyelid morphology J:89227
abnormal pupillary reflex J:89227
abnormal retina development J:89227
abnormal retina rod cell outer segment morphology J:89227
abnormal rod electrophysiology J:89227
abnormal vision J:89227
decreased amacrine cell number J:89227
decreased body size J:89227
impaired righting response J:89227
postnatal lethality, complete penetrance J:89227
Ntrk2tm1Rohr/Ntrk2tm1Rohr
Not Specified
abnormal optic nerve morphology J:119332
decreased body weight J:119332
decreased circulating follicle stimulating hormone level J:88782
decreased granulosa cell proliferation J:88782
decreased secondary ovarian follicle number J:88782
impaired granulosa cell differentiation J:88782
impaired ovarian folliculogenesis J:88782
postnatal lethality, complete penetrance J:119332
Ntrk2tm2.1Ddg/Ntrk2tm2.1Ddg
involves: 129P2/OlaHsd
abnormal sensory neuron innervation pattern J:192549
Ntrk2tm2.1Ddg/Ntrk2tm2.1Ddg
involves: 129S6/SvEvTac
abnormal survival J:218012
Ntrk2tm2.1Ddg/Ntrk2tm2.1Ddg
involves: 129S6/SvEvTac * C57BL/6
neonatal lethality, complete penetrance J:196548
Ntrk2tm2.1Mini/Ntrk2tm2.1Mini
involves: 129P2/OlaHsd
abnormal axon fasciculation J:132562
abnormal cerebral cortex morphology J:132562
abnormal neuron differentiation J:132562
abnormal neuronal migration J:132562
abnormal vestibular labyrinth morphology J:132562
astrocytosis J:132562
postnatal growth retardation J:132562
postnatal lethality, complete penetrance J:132562
Ntrk2tm2.1Tes/Ntrk2tm2.1Tes
involves: 129S4/SvJae * C57BL/6J
abnormal axon extension J:193542
abnormal response to novel object J:193542
abnormal spatial working memory J:193542
normal behavior/neurological phenotype J:193542
normal nervous system phenotype J:193542
reduced long-term potentiation J:193542
Ntrk2tm2Kln/Ntrk2tm2Kln
involves: 129S2/SvPas
no abnormal phenotype detected J:58229
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Camk2a-cre)159Kln/?
involves: 129S2/SvPas * CBA/J
abnormal long-term potentiation J:130626
impaired synaptic plasticity J:130626
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Cck-cre,-lacZ)1Mini/0
involves: 129S2/SvPas * C57BL/6 * CBA
abnormal adipose tissue distribution J:210229
abnormal circadian behavior J:210229
abnormal circulating corticosterone level J:210229
abnormal GABAergic neuron physiology J:210229
abnormal lipid level J:210229
normal adipose tissue phenotype J:210229
adrenal cortical hyperplasia J:210229
normal behavior/neurological phenotype J:210229
hepatic steatosis J:210229
normal homeostasis/metabolism phenotype J:210229
impaired glucose tolerance J:210229
increased abdominal fat pad weight J:210229
increased adrenal gland zona fasciculata size J:210229
increased body weight J:210229
increased circulating insulin level J:210229
increased circulating leptin level J:210229
increased gonadal fat pad weight J:210229
increased liver weight J:210229
increased susceptibility to age related obesity J:210229
increased susceptibility to weight gain J:210229
increased total body fat amount J:210229
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Nes-cre)1Kln/0
involves: 129S2/SvPas * C57BL/6 * SJL
abnormal axon fasciculation J:132562
abnormal brain morphology J:132562
abnormal cerebral cortex morphology J:132562
abnormal cortical plate morphology J:132562
abnormal myelin sheath morphology J:132562
abnormal neuron differentiation J:132562
abnormal neuronal migration J:132562
abnormal somatosensory cortex morphology J:132562
abnormal visual cortex morphology J:132562
demyelination J:132562
hyperactivity J:132562
postnatal growth retardation J:132562
premature death J:132562
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Penk-cre,-lacZ)1Mini/0
involves: 129S2/SvPas
abnormal gait J:204429
normal behavior/neurological phenotype J:204429
enhanced behavioral response to cocaine J:204429
increased locomotor activity J:204429
induced hyperactivity J:204429
normal nervous system phenotype J:204429
Ntrk2tm2Lfp/Ntrk2tm2Lfp
Tg(Col2a1-cre)1Bhr/0
involves: 129 * C57BL/6 * SJL
decreased birth body size J:204227
decreased body length J:204227
decreased body size J:204227
decreased body weight J:204227
decreased long bone epiphyseal plate size J:204227
decreased width of hypertrophic chondrocyte zone J:204227
kyphosis J:204227
postnatal growth retardation J:204227
postnatal lethality, incomplete penetrance J:204227
Ntrk2tm2Lfr/Ntrk2tm2Lfr
Tg(Six3-cre)69Frty/?
Tg(Thy1-YFP)HJrs/?
involves: C57BL/6 * CBA * DBA/2
abnormal dendrite morphology J:122929
abnormal retina ganglion cell morphology J:122929
Ntrk2tm3.1(cre/ERT2)Ddg/Ntrk2tm3.1(cre/ERT2)Ddg
involves: 129S6/SvEvTac * C57BL/6
abnormal survival J:218012
Ntrk2tm4.1Ddg/Ntrk2tm4.1Ddg
Aviltm2(cre)Fawa/Avil+
involves: 129P2/OlaHsd * C57BL/6
abnormal sensory neuron innervation pattern J:192549

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory